These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22925575)

  • 1. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer.
    Rink M; Furberg H; Zabor EC; Xylinas E; Babjuk M; Pycha A; Lotan Y; Karakiewicz PI; Novara G; Robinson BD; Montorsi F; Chun FK; Scherr DS; Shariat SF
    Eur Urol; 2013 Apr; 63(4):724-32. PubMed ID: 22925575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
    Rink M; Xylinas E; Margulis V; Cha EK; Ehdaie B; Raman JD; Chun FK; Matsumoto K; Lotan Y; Furberg H; Babjuk M; Pycha A; Wood CG; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF;
    Eur Urol; 2013 Jun; 63(6):1082-90. PubMed ID: 22743166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer.
    Rink M; Xylinas E; Babjuk M; Hansen J; Pycha A; Comploj E; Lotan Y; Sun M; Karakiewicz PI; Abdennabi J; Fajkovic H; Loidl W; Chun FK; Fisch M; Scherr DS; Shariat SF
    J Urol; 2012 Dec; 188(6):2120-7. PubMed ID: 23083868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy.
    Rieken M; Shariat SF; Kluth LA; Fajkovic H; Rink M; Karakiewicz PI; Seitz C; Briganti A; Rouprêt M; Loidl W; Trinh QD; Bachmann A; Pourmand G
    Eur Urol; 2015 Dec; 68(6):949-56. PubMed ID: 26050111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of smoking status and cumulative smoking exposure on tumor recurrence of non-muscle-invasive bladder cancer.
    Li HM; Azhati B; Rexiati M; Wang WG; Li XD; Liu Q; Wang YJ
    Int Urol Nephrol; 2017 Jan; 49(1):69-76. PubMed ID: 27766490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy.
    Xylinas E; Kluth LA; Rieken M; Lee RK; Elghouayel M; Ficarra V; Margulis V; Lotan Y; Rouprêt M; Martinez-Salamanca JI; Matsumoto K; Seitz C; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF;
    BJU Int; 2014 Jul; 114(1):56-61. PubMed ID: 24053463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
    Rink M; Xylinas E; Trinh QD; Lotan Y; Margulis V; Raman JD; Fisch M; Lee RK; Chun FK; Abdennabi J; Seitz C; Pycha A; Zlotta AR; Karakiewicz PI; Babjuk M; Scherr DS; Shariat SF;
    BJU Int; 2013 Sep; 112(5):623-37. PubMed ID: 23465088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.
    Grotenhuis AJ; Ebben CW; Aben KK; Witjes JA; Vrieling A; Vermeulen SH; Kiemeney LA
    Urol Oncol; 2015 Feb; 33(2):65.e9-17. PubMed ID: 25023787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer.
    Simonis K; Shariat SF; Rink M;
    Curr Opin Urol; 2014 Sep; 24(5):492-9. PubMed ID: 24887046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.
    Ogihara K; Kikuchi E; Yuge K; Ito Y; Tanaka N; Matsumoto K; Miyajima A; Asakura H; Oya M
    Ann Surg Oncol; 2016 May; 23(5):1752-9. PubMed ID: 26671037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
    Bosschieter J; Nieuwenhuijzen JA; van Ginkel T; Vis AN; Witte B; Newling D; Beckers GMA; van Moorselaar RJA
    Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
    Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
    Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.
    Kwan ML; Haque R; Young-Wolff KC; Lee VS; Roh JM; Ergas IJ; Wang Z; Cannavale KL; Ambrosone CB; Loo RK; Aaronson DS; Quesenberry CP; Kushi LH; Tang L
    JAMA Netw Open; 2022 Nov; 5(11):e2244430. PubMed ID: 36449286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer.
    Lammers RJ; Witjes WP; Hendricksen K; Caris CT; Janzing-Pastors MH; Witjes JA
    Eur Urol; 2011 Oct; 60(4):713-20. PubMed ID: 21794974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of smoking on outcomes after intravesical bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder.
    Sfakianos JP; Shariat SF; Favaretto RL; Rioja J; Herr HW
    BJU Int; 2011 Aug; 108(4):526-30. PubMed ID: 21114611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.
    Ehdaie B; Furberg H; Zabor EC; Ostroff JS; Shariat SF; Bochner BH; Coleman JA; Dalbagni G
    BJU Int; 2013 Apr; 111(4):589-95. PubMed ID: 22642265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
    Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
    Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
    Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.